Ibu and Micro-k drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ibu (ibuprofen) and Micro-k (potassium chloride). Common drug interactions include arthralgia among females and colon cancer metastatic among males.

The phase IV clinical study analyzes what interactions people have when they take Ibu and Micro-k. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.

What is Ibu?

Ibu has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 246,531 Ibu users. Check the latest studies of Ibu.

What is Micro-k?

Micro-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 1,895 Micro-k users. Check the latest studies of Micro-k.



On Jul, 06, 2026

55 people who take Ibu and Micro-k together, and have interactions are studied.

Ibu and Micro-k drug interactions.

What are the common drug interactions of Ibu and Micro-K, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Cardiomegaly (increased size of heart than normal)
  3. Mitral valve incompetence (inefficient heart valve)
  4. Palpitations (feelings or sensations that your heart is pounding or racing)
  5. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  6. Vomiting
  7. Lung disorder (lung disease)
  8. Oedema peripheral (superficial swelling)
  9. Chest discomfort
  10. Chest pain

male:

  1. Colon cancer metastatic (cancer of colon spreads to other part of body)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Cough
  7. Dizziness
  8. Dyspnoea (difficult or laboured respiration)
  9. Faeces discoloured
  10. Hypotension (abnormally low blood pressure)

What are the common drug interactions of Ibu and Micro-K, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Hodgkin's disease (cancer originating from white blood cells)
  2. Impetigo (contagious skin infection)
  3. Keratoconjunctivitis sicca (inflammation of the conjunctiva and cornea of the eye with decreased tears)
  4. Lacrimation increased
  5. Lung disorder (lung disease)
  6. Lymphadenopathy (disease or enlargement of lymph nodes)
  7. Neuropathy peripheral (surface nerve damage)
  8. Oral herpes (viral infection of mouth)
  9. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  10. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)

30-39:

  1. Colon cancer metastatic (cancer of colon spreads to other part of body)
  2. Aortic valve sclerosis (narrowing of the aortic valve)
  3. Cardiac murmur (an heart sound in valve abnormality)
  4. Chest tightness
  5. Dyspnoea (difficult or laboured respiration)
  6. Mitral valve incompetence (inefficient heart valve)
  7. Nausea (feeling of having an urge to vomit)
  8. Oedema lower limb (fluid collection in tissue of lower leg)
  9. Sweating increased (excess sweating)
  10. Vomiting

40-49:

  1. Abdominal pain upper
  2. Anaemia (lack of blood)
  3. Ascites (accumulation of fluid in the abdominal cavity)
  4. Biliary tract disorder
  5. Blood bilirubin increased
  6. Cholecystitis (infection of gallbladder)
  7. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  8. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  9. Conjunctival disorder (conjunctival disease)
  10. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

50-59:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Injury
  3. Nausea (feeling of having an urge to vomit)
  4. Oedema peripheral (superficial swelling)
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Pneumonia
  8. Asthma
  9. Chest pain
  10. Dyspnoea (difficult or laboured respiration)

60+:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Constipation
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  5. Cyst (a closed sac)
  6. Diarrhoea
  7. Dyspnoea (difficult or laboured respiration)
  8. Facial palsy (paralysis of face nerve)
  9. Fall
  10. Injury

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 10 people, 18.18%
  2. Oropharyngeal Pain: 6 people, 10.91%
  3. High Blood Cholesterol: 6 people, 10.91%
  4. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 6 people, 10.91%
  5. Osteoporosis (bones weak and more likely to break): 3 people, 5.45%
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 5.45%
  7. Muscle Aches (muscle pain): 3 people, 5.45%
  8. Metastases To Bone (cancer spreads to bone): 3 people, 5.45%
  9. Heart Rate Irregular: 3 people, 5.45%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 5.45%

* Approximation only. Some reports may have incomplete information.

Do you take Ibu and Micro-k?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ibu and Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ibu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ibu and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micro-k and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen and potassium chloride (the active ingredients of Ibu and Micro-k, respectively), and Ibu and Micro-k (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: